CANCER RESEARCH TECHNOLOGY ANNOUNCE COLORECTAL CANCER RESEARCH COLLABORATION WITH ASTRAZENECA

Cancer Research Technology (CRT), the oncology-focused development and commercialisation company wholly owned by Cancer Research UK, announce that they have entered into an agreement with AstraZeneca focused on colorectal cancer. CRT (http://www.cancertechnology.com/pages/press/4thSeptember2006-AstraZeneca.html)